Capital Markets Event: View a recording and access materials presented at OXB’s Capital Markets Event held on 2nd June 2026.

VectorXcellerator: OXB has selected the first programmes to move forward through VectorXcellerator, supporting earlier collaboration in advanced therapies.

OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture.

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category.

Shortcode Testing

Event: Advanced Therapies Europe

Location: EuropeWhere: Barcelona, ESStart Date: 7th Sep, 2026End Date: 9th Sep, 2026Conference

Event: Meeting on the Mesa

Location: North AmericaWhere: Phoenix, AZ, USStart Date: 5th Oct, 2026End Date: 7th Oct, 2026Conference

Event: ESGCT (booth G-03)

Location: EuropeWhere: Hamburg, DEStart Date: 27th Nov, 2026End Date: 30th Oct, 2026Conference